Bavarian Nordic A/S (Bavarian Nordic A/S) EBIT per Share : $1.05 (TTM As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Bavarian Nordic A/S EBIT per Share?

Bavarian Nordic A/S's EBIT per Share for the three months ended in Dec. 2023 was $0.63. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $1.05.

During the past 3 years, the average EBIT per Share Growth Rate was 40.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Bavarian Nordic A/S's EBIT per Share or its related term are showing as below:

BVNRY' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -82.9 Med: 9.6 Max: 161.3
Current: 40.8

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Bavarian Nordic A/S was 161.30% per year. The lowest was -82.90% per year. And the median was 9.60% per year.

BVNRY's 3-Year EBIT Growth Rate is ranked better than
88.51% of 1305 companies
in the Biotechnology industry
Industry Median: 3.2 vs BVNRY: 40.80

Bavarian Nordic A/S's EBIT for the three months ended in Dec. 2023 was $146 Mil.

Bavarian Nordic A/S EBIT per Share Historical Data

The historical data trend for Bavarian Nordic A/S's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bavarian Nordic A/S EBIT per Share Chart

Bavarian Nordic A/S Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

Get a 7-Day Free Trial

-0.40

0.46

-0.24

-0.14

1.01

Bavarian Nordic A/S Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EBIT per Share	Get a 7-Day Free Trial															0.17	0.26	0.36	-0.21	0.63

Bavarian Nordic A/S EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Bavarian Nordic A/S's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	232.408	/	230.132
=	1.01

Bavarian Nordic A/S's EBIT per Share for the quarter that ended in Dec. 2023 is calculated as

	EBIT per Share		(Q: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	145.545	/	231.968
=	0.63

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.05

Bavarian Nordic A/S (OTCPK:BVNRY) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Bavarian Nordic A/S EBIT per Share Related Terms

Thank you for viewing the detailed overview of Bavarian Nordic A/S's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Bavarian Nordic A/S (Bavarian Nordic A/S) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bavarian Nordic A/S (OTCPK:BVNRY) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

BVNKF:USA BAVAc:UK 0DPB:UK BAVA:Denmark BV3:Germany

Address

Philip Heymans Alle 3, Hellerup, DNK, DK-2900

Website

https://www.bavarian-nordic.com

Bavarian Nordic A/S is a biotechnology company focused on the development, manufacturing, and commercialization of cancer immunotherapies and vaccines for infectious diseases. The company has a specific focus on diseases for which the unmet medical need is high. Bavarian generates revenue through government research and development and supply contracts, and from its commercial partnerships. The vast majority of the company's revenue is generated in the United States, Germany, and other geographic markets.